Skip to main content
MIT Corporate Relations
MIT Corporate Relations
Search
×
Read
Watch
Attend
About
Connect
MIT Startup Exchange
Search
Sign-In
Register
Search
×
MIT ILP Home
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
ILP Members
MIT Startup Exchange
User Menu and Search
Search
Sign-In
Register
MIT ILP Home
Toggle menu
Search
Sign-in
Register
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
ILP Members
MIT Startup Exchange
Back to Faculty/Researchers
Dr. Omar O Abudayyeh
Research Scientist
Co-Founder, Sherlock Biosciences
Primary DLC
McGovern Institute for Brain Research
MIT Room:
46-5023C
omarabu@mit.edu
http://mcgovern.mit.edu/profile/omar-abudayyeh/
Research Summary
Omar Abudayyeh works on novel genome editing and gene delivery tools, and applying these tools towards the study of aging. While CRISPR is perhaps best known as a DNA editing tool, Abudayyeh’s team has discovered new CRISPR enzymes, such as the RNA-targeting CRISPR-Cas13, and adapted these enzymes for novel technologies, such as a simple and inexpensive tool to detect human disease. This technology, called SHERLOCK, can detect viruses, bacteria – even genetic signatures associated with cancer – in virtually any location. Abudayyeh and McGovern Fellow Jonathan Gootenberg continue to mine bacterial systems for new technologies to better enable gene therapy as well as applying these technologies towards studying mechanisms of aging.
Using next-generation single-cell sequencing and novel tools for perturbing cell states, Dr. Abudayyeh is determining, with unprecedented resolution, the cell types that arise in the aging brain and how mechanisms, such as senescence, drive detrimental processes in tissues. The ultimate goal is to use this information for building a detailed roadmap of aging circuits and to eventually reverse states of aging for regenerating tissues like the brain.
Recent Work
Video
4.4.23-Health-Gootenberg-Abudayyeh
April 4, 2023
Conference Video
Duration: 34:13
Show more
Molecular Technologies for Genome Editing and Cell Control
Related Faculty
Alexander Friedman
Research Scientist
Kathleen D Sullivan
Program Manager, Center for Biological & Computational Learning (CBCL)
Dr. Jill R Crittenden
Research Scientist